Kymera Therapeutics Inc. (KYMR)

AI Score

Unlock

32.97

2.27 (7.39%)

At close: Apr 24, 2025, 1:31 PM

Kymera Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q4 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Dec 31, 2019
Cash & Equivalents	120.26M	110.72M	67.61M	93.51M	109.97M	81.05M	52.39M	50.15M	68.39M	155.66M	76.91M	33.73M	47.98M	156.82M	84.9M	53.1M	31M	54.59M	60.97M	76.02M
Short-Term Investments	368.49M	439.25M	442.34M	427.03M	264.92M	276.77M	315.19M	346.73M	338.77M	326.25M	315.39M	387.08M	394.44M	379.57M	274.2M	280.44M	265.2M	239.25M	94.99M	15.94M
Long-Term Investments	362.16M	361.04M	198.29M	230.22M	61.43M	76.99M	104.76M	119.02M	152.33M	113.7M	90.18M	102.48M	125.19M	74.69M	45.3M	101.64M	162.53M	187.46M	n/a	n/a
Other Long-Term Assets	7.74M	5.78M	1.89M	2.12M	7.93M	8.6M	8.6M	-95.04M	-122.02M	9.13M	8.54M	8.13M	-98.77M	2.31M	2.51M	1.62M	11.46M	1.59M	2.52M	1.77M
Receivables	947K	1.32M	1.7M	2.03M	18.76M	3.78M	4.12M	3.32M	2.54M	2.88M	2.37M	1.26M	135K	1.57M	904K	1.73M	1.43M	577K	n/a	n/a
Inventory	n/a	n/a	n/a	1.00	1.00	n/a	1.00	-14.67M	-12.25M	n/a	n/a	n/a	-8.86M	n/a	n/a	n/a	-162.53M	n/a	n/a	n/a
Other Current Assets	20.58M	17.43M	13.75M	14.68M	11.67M	14.09M	13.71M	11.35M	9.71M	9.23M	8.09M	n/a	8.72M	5.77M	n/a	n/a	4.7M	n/a	n/a	n/a
Total Current Assets	510.27M	568.72M	525.41M	537.25M	405.32M	375.69M	385.4M	515.89M	559.49M	494.02M	402.77M	431.38M	567.61M	543.73M	364.81M	340.79M	302.34M	297.36M	158.3M	92.84M
Property-Plant & Equipment	97.86M	99.31M	100.44M	98.67M	101.08M	91.1M	83.18M	74.04M	13.33M	21.62M	21.93M	21.07M	11.88M	21.72M	21.77M	20.5M	10.84M	20.94M	20.29M	22.08M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	467.77M	466.13M	300.61M	331M	170.44M	176.68M	196.54M	98.01M	43.64M	144.45M	120.65M	131.68M	38.3M	98.72M	69.58M	123.76M	184.84M	210M	22.81M	23.86M
Total Assets	978.03M	1.03B	826.02M	868.25M	575.76M	552.38M	581.95M	613.9M	603.13M	638.47M	523.42M	563.06M	605.9M	642.45M	434.39M	464.55M	487.18M	507.36M	181.11M	116.7M
Account Payables	5.99M	6.49M	6.51M	6.81M	7.08M	4.98M	3.75M	6.48M	4.33M	6.33M	2.37M	2.57M	4M	5.03M	8.18M	8.35M	4.37M	3.98M	3.98M	3.28M
Deferred Revenue	13.58M	20.02M	19.26M	22.61M	37.88M	27.35M	24.3M	57.11M	63.26M	55.78M	59.46M	60.85M	101.03M	66.23M	82.26M	87.91M	170.39M	92.01M	27.29M	23.35M
Short-Term Debt	n/a	12.85M	12.42M	n/a	6.34M	3.6M	3.8M	n/a	n/a	3.62M	3.66M	3.57M	n/a	3.63M	3.46M	3.05M	n/a	n/a	n/a	n/a
Other Current Liabilities	223K	4.78M	5.4M	12.25M	16.82M	15.59M	14.01M	15.72M	303K	3.25M	361K	15.5M	17.17M	12.1M	9M	6.51M	5.93M	689K	3.89M	2.71M
Total Current Liabilities	67.77M	66.53M	62.14M	56.14M	85.69M	63.17M	54.6M	123.54M	63.26M	91.12M	87.5M	88.34M	101.03M	94.49M	108.69M	110.14M	110.62M	107.29M	42.68M	34.57M
Long-Term Debt	n/a	n/a	75.77M	n/a	78.33M	77.25M	71.26M	64.86M	n/a	13.12M	13.63M	13.9M	n/a	14.81M	14.84M	14.42M	n/a	15.08M	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	-75.77M	n/a	-78.33M	-77.24M	-71.03M	-64.63M	248K	-12.87M	-13.37M	-13.63M	66K	-14.73M	-14.76M	-14.33M	100K	-15.08M	n/a	109.08M
Total Long-Term Liabilities	74.65M	75.38M	78.95M	100.91M	95.1M	93.68M	91.92M	28.36M	49.72M	34.46M	37.97M	46M	45.23M	64.83M	67.6M	79.17M	92.67M	105.39M	34.39M	156.54M
Total Liabilities	142.42M	141.91M	141.1M	157.05M	180.79M	156.84M	146.52M	151.9M	112.98M	125.59M	125.47M	134.34M	146.27M	159.32M	176.28M	189.31M	203.29M	212.68M	77.07M	191.11M
Total Debt	87.76M	88.23M	88.18M	87.02M	84.67M	80.84M	75.06M	66.43M	17.34M	16.74M	17.29M	17.47M	17.96M	18.44M	18.3M	17.47M	17.99M	17.82M	19.1M	21.19M
Common Stock	7K	7K	6K	6K	6K	6K	6K	6K	6K	6K	5K	5K	5K	5K	5K	4K	4K	4K	3K	n/a
Retained Earnings	-754.61M	-683.86M	-621.37M	-579.31M	-530.75M	-516.38M	-463.52M	-424.72M	-383.79M	-348.93M	-305.92M	-265.67M	-228.98M	-195.08M	-166.5M	-141.84M	-128.76M	-116.08M	-108.09M	-76.46M
Comprehensive Income	-1.49M	1.93M	-2.1M	-1.78M	-552K	-2.45M	-3.63M	-3.04M	-4.95M	-5.91M	-3.98M	-3.22M	-660K	-146K	n/a	-13K	-128K	-164K	31K	6K
Shareholders Equity	835.62M	892.93M	684.92M	711.2M	394.97M	395.54M	435.43M	462M	490.15M	512.88M	397.95M	428.72M	459.64M	483.13M	258.1M	275.25M	283.89M	294.69M	104.04M	-74.41M
Total Investments	730.65M	800.29M	640.63M	657.25M	326.35M	276.77M	315.19M	346.73M	491.1M	439.95M	405.58M	489.56M	519.63M	454.26M	319.51M	382.08M	427.73M	426.71M	94.99M	15.94M